Search

Your search keyword '"Sudo, Kazuki"' showing total 615 results

Search Constraints

Start Over You searched for: Author "Sudo, Kazuki" Remove constraint Author: "Sudo, Kazuki"
615 results on '"Sudo, Kazuki"'

Search Results

1. Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial

4. A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer

13. Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy

15. Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma

18. Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy

20. Wavelet transform-based mode decomposition for EEG signals under general anesthesia.

25. Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information

26. A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

29. Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma

30. Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors.

33. Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project

35. Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study.

36. Increased Insulin Requirements in Severe Cases of Covid-19 are Higher Than in Moderate Cases.

37. Identification of barriers to implementation of precision oncology in patients with rare cancers

38. Potential marker subset of blood-circulating cytokines on hematopoietic progenitor-to-Th1 pathway in COVID-19

46. MO42-6 Analysis of sperm preservation in patients with mediastinal germ cell tumor patients

47. MO41-6 Trastuzumab-deruxtecan and blood inflammatory markers in HER2-positive metastatic breast cancer

48. MO33-2 Retrospective analysis of urothelial carcinoma treated with enfortumab vedotin at our institution

49. MO9-1 Clinical characteristics of HER2-low stage I triple-negative breast cancer

50. Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population

Catalog

Books, media, physical & digital resources